<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>56</volume><submitter>von der Grun J</submitter><funding>Varian Medical Systems Inc</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The FLASH effect is considered being the widening of the therapeutic window at (ultra-)high dose rates due to sparing of normal tissues while preserving tumor response. Our goal was to provide first data on the safety in treating a patient using a conventional linear accelerator converted to deliver 9 MeV UHDR electron beams in the research setting.&lt;h4>Material &amp; methods&lt;/h4>A conventional Varian TrueBeam linac was converted in the research setting to become capable of delivering 9 MeV UHDR electron beams. A phase I trial protocol was approved by the local authorities (NCT06549439). One patient with ≥ 1 melanoma (sub)-cutaneous lesion(s) was treated with 3x 9 Gy. The first two fractions were applied via e-Flash and the third via conventional electrons.&lt;h4>Results&lt;/h4>Her</pubmed_abstract><journal>Clinical and translational radiation oncology</journal><pagination>101047</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12509727</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>First-in-human e-Flash radiotherapy using a modified conventional C-arm linear accelerator.</pubmed_title><pmcid>PMC12509727</pmcid><pubmed_authors>Balermpas P</pubmed_authors><pubmed_authors>Psoroulas S</pubmed_authors><pubmed_authors>Guckenberger M</pubmed_authors><pubmed_authors>Sharma RA</pubmed_authors><pubmed_authors>von der Grun J</pubmed_authors><pubmed_authors>Mangana J</pubmed_authors><pubmed_authors>Fesslmeier D</pubmed_authors><pubmed_authors>Tirpak L</pubmed_authors><pubmed_authors>Smith W</pubmed_authors><pubmed_authors>Vilalta M</pubmed_authors><pubmed_authors>Dal Bello R</pubmed_authors><pubmed_authors>Ramelyte E</pubmed_authors><pubmed_authors>Tanadini-Lang S</pubmed_authors><pubmed_authors>Krayenbuehl J</pubmed_authors></additional><is_claimable>false</is_claimable><name>First-in-human e-Flash radiotherapy using a modified conventional C-arm linear accelerator.</name><description>&lt;h4>Background&lt;/h4>The FLASH effect is considered being the widening of the therapeutic window at (ultra-)high dose rates due to sparing of normal tissues while preserving tumor response. Our goal was to provide first data on the safety in treating a patient using a conventional linear accelerator converted to deliver 9 MeV UHDR electron beams in the research setting.&lt;h4>Material &amp; methods&lt;/h4>A conventional Varian TrueBeam linac was converted in the research setting to become capable of delivering 9 MeV UHDR electron beams. A phase I trial protocol was approved by the local authorities (NCT06549439). One patient with ≥ 1 melanoma (sub)-cutaneous lesion(s) was treated with 3x 9 Gy. The first two fractions were applied via e-Flash and the third via conventional electrons.&lt;h4>Results&lt;/h4>Her</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-15T07:47:21.205Z</modification><creation>2026-07-01T03:07:58.645Z</creation></dates><accession>S-EPMC12509727</accession><cross_references><pubmed>41080989</pubmed><doi>10.1016/j.ctro.2025.101047</doi></cross_references></HashMap>